BICB (BioCube) Current Accrued Expense: $0.08 Mil (As of Jul. 2013)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is BioCube Current Accrued Expense?

BioCube BICB -99.00% Current Accrued Expense is $0.08 Mil as of Jul. 2013.

BioCube's Current Accrued Expense for the quarter that ended in Jul. 2013 was $0.08 Mil.

BioCube's quarterly Current Accrued Expense increased from Jan. 2013 ($0.03 Mil) to Apr. 2013 ($0.05 Mil) and increased from Apr. 2013 ($0.05 Mil) to Jul. 2013 ($0.08 Mil).

BioCube's annual Current Accrued Expense declined from Jan. 2011 ($0.01 Mil) to Jan. 2012 ($0.00 Mil) but then increased from Jan. 2012 ($0.00 Mil) to Jan. 2013 ($0.03 Mil).

BioCube Current Accrued Expense Historical Data

* Premium members only.

The historical data trend for BioCube's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioCube Current Accrued Expense Chart

BioCube Annual Data
Trend Jun06 Jun07 Jan08 Jan09 Jan11 Jan12 Jan13
Current Accrued Expense
Get a 7-Day Free Trial 0.10 0.10 0.01 0.00 0.03

BioCube Quarterly Data
Apr08 Jul08 Oct08 Jan09 Apr09 Oct09 Apr10 Jul10 Oct10 Jan11 Apr11 Jul11 Oct11 Jan12 Apr12 Jul12 Oct12 Jan13 Apr13 Jul13
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.01 0.03 0.05 0.08

BioCube Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

What does a Current Accrued Expense of $0.08 Mil mean?
BioCube (BICB) has a Current Accrued Expense of $0.08 Mil as of Jul. 2013. Current Accrued Expense records the total amount of accrued expenses. View historical data on BioCube and its competitors.
Is BioCube's Current Accrued Expense too high?
BioCube's current Current Accrued Expense is $0.08 Mil.
How does BioCube's Current Accrued Expense compare to MBVXQ and GWSN?
BioCube's Current Accrued Expense of $0.08 Mil can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Accrued Expense for a Diversified Financial Services company?
A good Current Accrued Expense depends on the Diversified Financial Services industry context. However, Current Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Accrued Expense mean?
A high Current Accrued Expense can signal that a stock is expensive relative to its fundamentals. Current Accrued Expense records the total amount of accrued expenses. View historical data on BioCube and its competitors. BioCube's current Current Accrued Expense is $0.08 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioCube stock overvalued right now?
BioCube (BICB) has a current Current Accrued Expense of $0.08 Mil. The current Current Accrued Expense is $0.08 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Accrued Expense calculated?
Current Accrued Expense is calculated from a company's financial statements. For BioCube (BICB), the current Current Accrued Expense is $0.08 Mil as of Jul. 2013. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BioCube Business Description

Address 3060 West 3680 South, Suite 92, West Valley, UT, USA, 84119
BioCube Inc is a shell company.